Amendment to Commitment LetterCommitment Letter Amendment • November 8th, 2016 • Grand Chip Investment GmbH • Special industry machinery, nec • Hong Kong
NOW THEREFORE, for various considerations, receipt and sufficiency thereof being hereby expressly acknowledged by each of the parties hereto, the parties hereto do mutually agree and confirm to each other as follows:
Commitment Letter AmendmentCommitment Letter Amendment • December 21st, 2020 • Telenav, Inc. • Search, detection, navagation, guidance, aeronautical sys
Reference is hereby made to that certain Commitment Letter, dated November 2, 2020 (together with all annexes and exhibits thereto, the “Commitment Letter”), by and among Samuel T. Chen, H.P. Jin, Digital Mobile Venture Limited (collectively, the “Commitment Parties”) and V99, Inc. (“Parent”) which was entered into in connection with that certain Merger Agreement, dated November 2, 2020, by and among Parent, Telenav99, Inc. and Telenav, Inc. (as the same has been amended, restated, supplemented or otherwise modified from time to time in a manner not materially adverse to the Commitment Parties, the “Merger Agreement”). All capitalized terms used but not defined herein shall have the respective meanings given to them in the Commitment Letter, as amended by this Amendment.
AMENDMENT to FIRMINVEST AG COMMITMENT LETTERCommitment Letter Amendment • August 17th, 2007 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations
This Amendment (the “Amendment”), effective as of June 30, 2007 (the “Effective Date”), is attached to and made part of the commitment letter dated May 20, 2007 and accepted on May 21, 2007 (the “Commitment Letter”) between FirmInvest AG (“FirmInvest”) and CardioVascular BioTherapeutics, Inc., a Nevada corporation (“Cardio”) regarding a foreign private placement being conducted under Regulation S of the Securities Act of 1993 to sell 15,000,000 shares of common stock of CardioVascular BioTherapeutics, Inc. at US$1.00 per shares (the “Reg S Offering”).
